onxeo
  • English
  • Français
>>>>
    • News
    • Agenda
    • Subscribe to news

Get to know AsiDNA

View corporate presentation

BECOME A PARTNER
BECOME A SHAREHOLDER

NEWS >

Onxeo to Present Five Preclinical Studies Highlighting AsiDNA™ Unique Profile and its clinical potential in Oncology at 2019 American Association for Cancer Research Annual Meeting

Onxeo Announces Identification of Predictive Biomarkers for AsiDNA™, its First-in-Class DNA Damage Response Inhibitor

AGENDA >

Intervention of Judith Greciet at Les Echos/Investir

back up ↑
  • Terms of use
  • Contact
© Copyright 2019 onxeo | The sections “The group”, “Our products”, “Partnerships”, “Investors”, “Media” are dedicated to investors. | Webdesign : Limbus Studio